Identification of peripheral CD154+ T-cells and HLA-DRB1 as biomarkers
of acute cellular rejection in adult liver transplant recipients
Abstract
Decreasing graft rejection and increasing graft and patient survival are
great challenges facing liver transplantation (LT). Different T-cell
subsets participates in the acute cellular rejection (ACR) of the
allograft. Cell-mediated immunity markers of the recipient could help to
understand the mechanisms underlying acute rejection. This study aimed
to analyse CD4+CD154+ and CD8+CD154+ T-cells in a cohort of adult liver
patients undergoing LT to determine the influence on ACR using
multiparametric flow cytometry functional assay. Thiry patients were
immunologically monitored at baseline and during 1 year post-transplant.
Two groups were established, with (ACR) and without (NACR) acute
cellular rejection. Leukocyte, total lymphocyte, percentages of
CD4+CD154+ and CD8+CD154+ T-cells, HLA mismatch between recipient-donor
and their relation with ACR as well as the acute rejection frequencies
were analysed. T-cells were stimulated with concanavalin A (Con-A) and
surface antigens were analysed by FACS analysis. A high percentage of
CD4+CD154+ T-cells (p=0.001) and a low percentage of CD8+CD154+ T-cells
(p=0.002) at baseline were statistically significant in ACR. A receiver
operating characteristic analysis determined the cut-off values capable
to stratify patients at high risk of ACR with high sensitivity and
specificity for CD4+CD154+ (p=0.001) and CD8+CD154+ T-cells (p=0.002).
In logistic regression analysis, CD4+CD154+, CD8+CD154+ and HLA mismatch
were confirmed as independent risk factors to ACR. Post-transplant
percentages of both T-cell subsets were significantly higher in ACR,
despite variations compare to pre-transplant. These findings support the
selection of candidates for LT based on the pre-transplant percentages
of CD4+CD154+ and CD8+CD154+ T-cells in parallel with other transplant
factors